Jump to content
RemedySpot.com

Mira Shiva on counterfeits

Rate this topic


Guest guest

Recommended Posts

Hi all,

Mira Shiva is a big name in medical activism in India.

Below her opinion on counterfeits.

Being shared with NetRUMians.

Vijay

-----------------------------------------------

There is a public Health aspect of the Counterfeit drugs linked to

safety , because of substard contents , wilful adulteration as in the

case of Glycerol - see Lentin Commission Report .

The trade mark violation is a trade issue & must be handled by

another

body & not the inadequately staffed Drug Regulatory System ,

detracting

it from its primary role of Regulating to ensure Safety , Efficacy of

Medicines for Public Health .

For those engaged in the issue of Counterfeit drugs from public

Health

view point , the fact that the changed defination is to protect the

trade interest of the manufacturer is unlikely to be known .

Adding to this is the fact that this changed defination with ,

legal

tools to back it will be used to kill generic competition ,create

insecurity & evenengage generic manufacturers in long drawn legal

battles .

Majority of the people need generic equavalents , because of the

cost factor , much more so in this period of financial crisis .

Earlier WHO defination of WHO on Counterfeit drugs must remain .

Dr Mira Shiva

Initiative for Health Equity & Society

All India Drug Action Network

A 60 Hauz Khas

New Delhi

110016

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...